Leptin particulates in cholesterol-regulating functions via proprotein convertase subtilisin/kexin type 9 pathway and down-regulates expression of LDL receptors in hepatocytes, leading to elevated plasma LDL-C levels and dyslipidemia [35]. The gene discussed is PCSK9; the disease is metabolic syndrome.